Antiretroviral-related hematologic short-term toxicity in healthy infants: implications of the new neonatal 4-week zidovudine regimen

Emilia Sánchez Ruiz, Rebeca Lahoz, Antoni Noguera, Núria Rovira, Albert Català-Temprano, Rafael Jiménez, Clàudia Fortuny

Producció científica: Article en revista indexadaArticle

22 Cites (Scopus)

Resum

Recent updates of the guidelines on the prevention of human immunodeficiency virus mother-to-child transmission have shortened the neonatal zidovudine prophylactic regimens from 6 to 4 weeks. We present a prospective observational study in a large cohort of mother-infant pairs and report that the 4-week regimen allows an earlier recovery of the anemia in these otherwise healthy infants.
Idioma originalAnglès
Pàgines (de-a)376-379
Nombre de pàgines4
RevistaPediatric Infectious Disease Journal
Volum29
Número4
DOIs
Estat de la publicacióPublicada - 1 d’abr. 2010

Fingerprint

Navegar pels temes de recerca de 'Antiretroviral-related hematologic short-term toxicity in healthy infants: implications of the new neonatal 4-week zidovudine regimen'. Junts formen un fingerprint únic.

Com citar-ho